Medicare Enrolled
Dr. Marie Cheryle Lingat, MD
Pulmonary Disease · Hudson, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lingat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lingat?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lingat
Dr. Marie Cheryle Lingat is a pulmonary disease specialist in Hudson, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lingat performed 1,022 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lingat received a total of $11,876 from 43 pharmaceutical and/or device companies across 653 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lingat is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 40% volume in NY
$11,876 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,022
Medicare services
Top 40% in NY for pulmonary disease
Not available
Unique patients (not deduplicated)
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
244 | $78 | $161 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
168 | $99 | $366 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
162 | $52 | $119 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
69 | $9 | $73 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
69 | $115 | $237 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
66 | $10 | $53 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
66 | $8 | $38 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
56 | $185 | $1,070 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $108 | $283 |
| New patient office visit, complex (60-74 min) | 23 | $144 | $350 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $138 | $606 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
17 | $77 | $238 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
16 | $17 | $204 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
13 | $32 | $86 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
13 | $13 | $57 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$11,876
Total received (2018-2024)
Avg $1,697/year across 7 years
Top 16% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
653
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,442
2023
$1,801
2022
$1,724
2021
$1,116
2020
$800
2019
$2,098
2018
$1,894
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$654
GlaxoSmithKline, LLC.
$465
Regeneron Healthcare Solutions, Inc.
$204
Boehringer Ingelheim Pharmaceuticals, Inc.
$178
Philips North America LLC
$153
GENZYME CORPORATION
$143
Takeda Pharmaceuticals U.S.A., Inc.
$139
Pulmonx Corporation
$117
Actelion Pharmaceuticals US, Inc.
$77
Insmed, Inc.
$60
Amgen Inc.
$48
Mylan Specialty L.P.
$43
Mallinckrodt Hospital Products Inc.
$43
Janssen Pharmaceuticals, Inc
$32
PFIZER INC.
$30
Grifols USA, LLC
$23
Axsome Therapeutics, Inc.
$17
Lexicon Pharmaceuticals, Inc.
$16
Top 3 companies account for 54.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,628
AstraZeneca Pharmaceuticals LP
$2,214
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,103
GENZYME CORPORATION
$845
Regeneron Healthcare Solutions, Inc.
$527
Janssen Pharmaceuticals, Inc
$493
Philips Electronics North America Corporation
$463
Grifols USA, LLC
$452
Takeda Pharmaceuticals U.S.A., Inc.
$248
Actelion Pharmaceuticals US, Inc.
$241
Mallinckrodt Hospital Products Inc.
$240
Pulmonx Corporation
$225
Shire North American Group Inc
$223
PFIZER INC.
$200
Insmed, Inc.
$166
Mylan Specialty L.P.
$154
Philips North America LLC
$153
Circassia Pharmaceuticals Inc
$131
Novartis Pharmaceuticals Corporation
$126
JAZZ PHARMACEUTICALS INC.
$117
Allergan Inc.
$93
Mallinckrodt LLC
$87
Genentech USA, Inc.
$86
Sunovion Pharmaceuticals Inc.
$80
Merck Sharp & Dohme Corporation
$76
Paratek Pharmaceuticals, Inc.
$62
Teva Pharmaceuticals USA, Inc.
$55
Amgen Inc.
$48
United Therapeutics Corporation
$44
Itamar Medical Inc
$37
Avanir Pharmaceuticals, Inc.
$32
E.R. Squibb & Sons, L.L.C.
$29
Mallinckrodt Enterprises LLC
$24
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$24
Vapotherm Inc
$21
Baxter Healthcare
$19
Merck Sharp & Dohme LLC
$19
Allergan, Inc.
$18
Axsome Therapeutics, Inc.
$17
Lexicon Pharmaceuticals, Inc.
$16
Alexion Pharmaceuticals, Inc.
$16
Melinta Therapeutics, Inc.
$13
SANOFI PASTEUR INC.
$11
Top 3 companies account for 50.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · ASMANEX · AVYCAZ · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · CHANTIX · CHARTIS CATHETER · CUVITRU · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · ENTRESTO · Esbriet · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · INVOKANA · LONHALA MAGNAIR · LifeVest · NUCALA · NUEDEXTA · NUZYRA · OFEV · OPSUMIT · PAXLOVID · PREVNAR 20 · Precision Flow · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · REMODULIN · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · WatchPATONE · Wellcentive Undiv · XARELTO · XOLAIR · Xembify · Xolair · YUPELRI · ZEPHYR DELIVERY CATHETER · ZERBAXA · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
3
County median income
$83,619
Nearest hospital to ZIP centroid (approximate)
COLUMBIA MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lingat is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lingat experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lingat performed 244 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lingat receive payments from pharmaceutical companies?
Yes. Dr. Lingat received a total of $11,876 from 43 companies across 653 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lingat's costs compare to other pulmonary diseases in Hudson?
Dr. Lingat's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lingat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Hudson
Browse pulmonary diseases in Hudson ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology